chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: F
Vaccine: HEP
Symptoms: Incorrect dose administered
Clinical narrative: Patient received a full dose (20+ age dose) pt was 18 at time of vaccine
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient was give 0.25ml (not the full 0.5ml that she was supposed to receive).  I got the recommended info from Moderna to complete the vaccine.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient was give 0.25ml (not the full 0.5ml that she was supposed to receive).  I got the recommended info from Moderna to complete the vaccine.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Atrial fibrillation, Condition aggravated
Clinical narrative: Afib symptoms within an 1.5 hours after vaccine injection.   I haven't had afib symtpoms in a very long time and experienced them after the vaccination.  Symptoms lasted 7 hours and went away on their own.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: 17 year old given pediatric dose of pfizer COVID vaccines
Age: 60.0
Sex: F
Vaccine: FLU4
Symptoms: Incorrect dose administered, Needle issue, Underdose
Clinical narrative: Reporter was giving client influenza vaccine. When administering, vaccine shot backward out of hub of needle instead of through the needle into patient arm. Patient received less than 25% of vaccine. Was revaccinated.
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Blood test, Deep vein thrombosis, Pain in extremity, Ultrasound scan abnormal
Clinical narrative: 9/17/2022 - pain started in left calf during the night 9/18/2022 - pain in calf continued 9/19/2022- pain continued/ getting worse - went to Urgent Care who encouraged me to go to Emergency for Ultrasound 9/19/2022 - Emergency Room visit - ultra sound of left leg veins - it was observed on the ultra sound I had "slow flow" and they decided to treat it as a DVT. I had blood work up done and was sent home with Eliquis to start taking. They also asked me to follow up with a Vascular Surgeon and have another ultra sound in 2 weeks. 9/21/2022 - followed up with my primary care doctor who also confirmed a blot clot.
Age: 84.0
Sex: M
Vaccine: VARZOS
Symptoms: Muscle spasms, Pain in extremity
Clinical narrative: Patient reported severe pain and cramps around calf-muscle, pt reported to a local hospital for the pain
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature increased, COVID-19, Cough, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Pt to ED 8/20 for acute mental change. 9/15 pt had temp 101, with a cough. 9/16 pt COVID+, rx remdesivir for 3 days. 9/17 pt A&OX2, no sign of distress or pain. 9/18 pt a&ox2, no needs expressed. No sign of discomfort or distress. Pt discharged 9/19.
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chromaturia, Disorientation, Dizziness, Ear pain, Headache
Clinical narrative: Five minutes after I receive the shot, my arm started to hurt really bad which has never happened before. Started to pass out as I was driving home. Was able to pull over before completely losing consciousness. When I woke up I had urinated myself and was very disoriented. I was very restless the rest of the day.  Very dizzy and nauseous with a severe headache and sharp right ear pain throughout the day/night. The following morning my pee was very amber which has also never happened before, but cleared up as the day went on. My throat felt swollen as well. I  have never had a reaction like this to any vaccination.
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Loss of consciousness, Nausea, Pain in extremity, Pharyngeal swelling, Restlessness
Clinical narrative: Five minutes after I receive the shot, my arm started to hurt really bad which has never happened before. Started to pass out as I was driving home. Was able to pull over before completely losing consciousness. When I woke up I had urinated myself and was very disoriented. I was very restless the rest of the day.  Very dizzy and nauseous with a severe headache and sharp right ear pain throughout the day/night. The following morning my pee was very amber which has also never happened before, but cleared up as the day went on. My throat felt swollen as well. I  have never had a reaction like this to any vaccination.
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urinary incontinence
Clinical narrative: Five minutes after I receive the shot, my arm started to hurt really bad which has never happened before. Started to pass out as I was driving home. Was able to pull over before completely losing consciousness. When I woke up I had urinated myself and was very disoriented. I was very restless the rest of the day.  Very dizzy and nauseous with a severe headache and sharp right ear pain throughout the day/night. The following morning my pee was very amber which has also never happened before, but cleared up as the day went on. My throat felt swollen as well. I  have never had a reaction like this to any vaccination.
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: Bad headache, muscle ache, tired
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient and his wife came to our pharmacy to receive their bivalent Moderna boosters. One syringe was drawn from the correct bivalent vial and the second was drawn incorrectly from a monovalent Moderna vial. After review of video footage, we could not determine which patient received the incorrect monovalent dose. The patients were notified. No adverse events to report. We are in contact with Moderna and the CDC to determine if re-vaccinating with the bivalent dose in 2 months is appropriate.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Eye irritation, Eye pain, Lacrimation increased, Photophobia, Reading disorder
Clinical narrative: 24 hours after vaccination -stinging, burning eyes with excessive tearing, and couldn't stand bright light. Wasn't able to read or watch TV due to  tearing & light. Awful runny nose. Symptoms were better on September 22.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rhinorrhoea
Clinical narrative: 24 hours after vaccination -stinging, burning eyes with excessive tearing, and couldn't stand bright light. Wasn't able to read or watch TV due to  tearing & light. Awful runny nose. Symptoms were better on September 22.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death
Clinical narrative: PFIZER COVID VACCINE #3 GIVEN 9/8/21, LOT #FC3182; patient passed away at home with COD: complications of COVID 19; no medical records on this patient; PCP unknown.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: 5-11 dose was given to the patient
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient and her husband came to our pharmacy to receive their bivalent Moderna boosters. One syringe was drawn from the correct bivalent vial and the second was drawn incorrectly from a monovalent Moderna vial. After review of video footage, we could not determine which patient received the incorrect monovalent dose. The patients were notified. No adverse events to report. We are in contact with Moderna and the CDC to determine if re-vaccinating with the bivalent dose in 2 months is appropriate.
Age: 57.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient was give 0.25ml (not the full 0.5ml that she was supposed to receive).  I got the recommended info from Moderna to complete the vaccine.
Age: 54.0
Sex: F
Vaccine: FLUR4, VARZOS
Symptoms: Rash, Rash erythematous, Rash papular
Clinical narrative: Pt reports raised red rash in right arm and seeking medical attention
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient was give 0.25ml (not the full 0.5ml that she was supposed to receive).  I got the recommended info from Moderna to complete the vaccine.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Hip arthroplasty, Joint dislocation, Patient uncooperative, SARS-CoV-2 test positive
Clinical narrative: Pt to ED 9/11  w/ c/o hip dislocation, pt COVID+ 9/10. Pt w/ even and unlabored respirations, AOx0 w/ response to painful stimuli. 9/12 pt is very uncooperative with care, to OR for Revision to a total hip arthroplasty. Post-surgery, pt is alert and oriented to 0. Not following commands, on room air. Pt discharged 9/14.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19, Cough, Diarrhoea, Dyspnoea
Clinical narrative: covid positive on 9/21/22 with symptoms of cough and shortness of breath , and abdominal pain and diarrhea
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: covid positive on 9/21/22 with symptoms of cough and shortness of breath , and abdominal pain and diarrhea
Age: 84.0
Sex: M
Vaccine: UNK
Symptoms: Blood test, Computerised tomogram, Eye movement disorder, Eye swelling, Headache
Clinical narrative: Right eye swelling, right eyeball will not move past midline on right side.  Intermittent pain/spasm on right side of head and above right eye near eyebrow.
Age: 84.0
Sex: M
Vaccine: UNK
Symptoms: Magnetic resonance imaging, Muscle spasms
Clinical narrative: Right eye swelling, right eyeball will not move past midline on right side.  Intermittent pain/spasm on right side of head and above right eye near eyebrow.
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient was give 0.25ml (not the full 0.5ml that she was supposed to receive). I got the recommended info from Moderna to complete the vaccine.
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient was give 0.25ml (not the full 0.5ml that she was supposed to receive).  I got the recommended info from Moderna to complete the vaccine.
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Dizziness, Dysstasia, Fatigue, Syncope
Clinical narrative: I felt very tired, but I was doing okay. I was standing at my desk on a video call and started feeling dizzy. My vision started to blur. The next thing I knew, I was on the floor. I fainted. I tried standing back up to finish the call, but I didn't have the energy. It was a few minutes before I could stand again. I was okay for the rest of the day, but I still felt tired.
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vision blurred
Clinical narrative: I felt very tired, but I was doing okay. I was standing at my desk on a video call and started feeling dizzy. My vision started to blur. The next thing I knew, I was on the floor. I fainted. I tried standing back up to finish the call, but I didn't have the energy. It was a few minutes before I could stand again. I was okay for the rest of the day, but I still felt tired.
Age: 28.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Swelling face, Tenderness
Clinical narrative: Nose bridge swollen started on Day 3. Upper bridge of the nose was visibly swollen and tender. Went to an ETN doctor on 9/22 - he didnt find anything. He suspects that I might have touch the injection site and then my face, causing a skin infection. Doctor prescribed an ointment medication (Muripocin). Will start tomorrow (9/23) with treatment.   On 9/21, the day after getting the vaccine, I did apply medical ointment (Aquaphor) on the injection side. I'm not sure if I touched my face after applying it on my arm.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Condition aggravated, Tinnitus
Clinical narrative: Severe Tinnitus in left ear initially which has developed to severe in both ears now.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered
Clinical narrative: Pharmacy administered deauthorized booster dose on September 2, 2022. Dose given had been deauthorized on August 31, 2022.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: Pt did not have any adverse events.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case
Age: 54.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Immediate post-injection reaction, Paraesthesia
Clinical narrative: Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Immediately after Flulaval vaccination, patient with MS noticed numbness and tingling beginning in feet and working its way up her legs to the thighs over a period of 15-20 minutes.  Checked with her neurologist, who prescribed Prednisone for use if symptoms did not resolve.  Approx 75 min after onset, sx started to resolve, pt was able to leave.  She did not use Pred and was feeling normal next day.
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: Exposure during pregnancy, Incorrect product formulation administered, Vaccination error
Clinical narrative: Patient received Bivalent Pfizer vaccine instead of monovalent pfizer vaccine for 1st COVID vaccine in series on 09/16/2022.  Pt  at time of vaccine error is  30w and 5d, est due date is 11/20/2022. Pt has gestational diabetes and advanced maternal age during this pregnancy.
Age: 80.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema
Clinical narrative: Site: Redness at Injection Site-Mild, Additional Details: patient called pharmacy friday morning to ask about redness at and below injections site. Health Center called in the afternoon ,said patient called md to report redness at and below injection site
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID19
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Joint swelling, Limb discomfort, Skin discolouration
Clinical narrative: In addition to discomfort in the upper left arm which was expected and has resolved, the proximal interphalangeal joint on my right ring finger became extremely discolored. It is a dark purplish red. This started just around the PIP joint but appears to be moving down towards the main portion of the hand. I have osteoarthritis in this joint, but I have never experienced this discoloration before. There is not an excessive amount of swelling but very obvious discoloration. I am not able to take anti-inflammatory meds so I am at a loss to know bow to proceed.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case. Moderna 3/12/21 044A21A, 4/9/21 018B21A and boosted 12/2/21 FJ8762.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Error: Wrong Age for Vaccine Given-
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Sex: U
Vaccine: UNK
Symptoms: Incorrect product formulation administered
Clinical narrative: 8//31/2022. AM PATIENTS GOT MONOVALENT BOOSTERS AT CLINIC. WE WERE ALERTED LATER IN DAY TO NOT DO MONOVALENT AND USE THE BIVALENT MODERNA ONCE AVAILALBE. ALERTED STAFF. DISCARDED MONOVALENT VACCINE AND AWAITING BIVALENT TO ADMINISTER.  LOT 083822A. EXP 9/10/2022
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID19
Age: 31.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pruritus, Urticaria
Clinical narrative: At around 11pm on 9/19/2022 there was a sudden onset of hives on the upper back, inner arms (between elbow and shoulder on the side touching the torso), hives beneath the armpit on both sides, and on the posterior side of the thighs between the knee and glutes.   Within 3 hours the hives expanded rapidly with the entire back being covered in hives. Hives spread to the tops of the shoulders (deltoid area), and in spots all over the front of the torso. Consistent and strong feelings of itchiness were felt.  There were no respiratory issues. A hot bath, 2 doses of diphenhydramine 25mg (Benadryl), and one does of cetirizine (HCI)10mg (Zyrtec) was taken. I then went to sleep and 6 hours later all of the hives were gone.   On 9/21/2022 I went to my primary care doctor; I showed him photos I had taken of the hives (which are available upon request; he advised me to fill out this report. His examination resulted in finding no hives or symptoms during his physical examination.   On 9/21/2022 itchiness of the face with slight hives was felt. Anti-itch cream was applied and 8 hours later all itchiness ceased.   In the days before and after the vaccination, there were no changes in diet, vitamins, medication, or activity. I had not been in a pool or hot tub, nor exposed to any chemicals or allergens.
Age: 8.0
Sex: M
Vaccine: FLU4
Symptoms: Urticaria
Clinical narrative: Hives, Pt was given prednisone 20 mg tablets on 09/22/2022
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Balance disorder, Dizziness, Dysstasia, Gait disturbance, Myalgia
Clinical narrative: I began to feel dizzy, even while sitting. I got up to get a drink of water, but had great difficulty maintaining my balance, both while standing and trying to walk. I got the water and sat again for a while, but the dizziness returned. I then went to bed and as soon as I laid down on my back I started to experience the same sensation as when I suffered vertigo - the room began spinning. This went on a short while and I eventually went to sleep. I got up several times during the night and my balance was better when walking to the bathroom. By morning I felt mostly normal, except for the muscle pains I had experience with previous vaccinations.
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Vertigo
Clinical narrative: I began to feel dizzy, even while sitting. I got up to get a drink of water, but had great difficulty maintaining my balance, both while standing and trying to walk. I got the water and sat again for a while, but the dizziness returned. I then went to bed and as soon as I laid down on my back I started to experience the same sensation as when I suffered vertigo - the room began spinning. This went on a short while and I eventually went to sleep. I got up several times during the night and my balance was better when walking to the bathroom. By morning I felt mostly normal, except for the muscle pains I had experience with previous vaccinations.
Age: 84.0
Sex: F
Vaccine: COVID19-2
Symptoms: Aspiration, Immunisation reaction, Lethargy, Pneumonia aspiration, Pyrexia
Clinical narrative: Received Pfizer bivalent on 9/20/22 at 10:45am.  On 9/21/22 at 8:10am resident developed a fever, lethargy, and vomiting. V/S 141/77 P-109, R-33, T-101.7, Spo2-86% on room air.  O2 was started at 3L/min.  911 was notified and resident transferred to a Hospital ER locally.  Was admitted to the hospital with diagnosis of intractable vomiting with aspiration resulting in aspiration pneumonia.  Dr. states pt. has prior history of similar reaction to last booster and I feed the adverse reaction are related to the bivalent booster.  Order was received at the HCF for resident to not received any further Covid-19 immunizations.
Age: 84.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vomiting
Clinical narrative: Received Pfizer bivalent on 9/20/22 at 10:45am.  On 9/21/22 at 8:10am resident developed a fever, lethargy, and vomiting. V/S 141/77 P-109, R-33, T-101.7, Spo2-86% on room air.  O2 was started at 3L/min.  911 was notified and resident transferred to a Hospital ER locally.  Was admitted to the hospital with diagnosis of intractable vomiting with aspiration resulting in aspiration pneumonia.  Dr. states pt. has prior history of similar reaction to last booster and I feed the adverse reaction are related to the bivalent booster.  Order was received at the HCF for resident to not received any further Covid-19 immunizations.
Age: 2.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Erythema multiforme
Clinical narrative: Nonbullous erythema  multiforme treated with benadryl as needed
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received second dose on day 13 instead of day 21
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event, Product administration error
Clinical narrative: This was NOT an adverse event.  It was a vaccine administration error.  We thought we were administering the Pfizer bivalent vaccine and discovered in the mid afternoon on 9/8/22 that we were actually administering the Pfizer Grey Cap (monovalent/original) formulation of the vaccine.  Upon discovery corrective action was taken.  Patient was notified of vaccine administration error as was the Department of Health.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Extra dose administered, Headache, Hypertension
Clinical narrative: I used to get headaches which would subside after some time. I started experiencing headaches 15 days post vaccine that were more severe and too a longer time to subside. I then noticed my bp was high and I was told to continue monitoring it. The bp remained high and the Dr. now has me on bp medication and has me making dietary changes.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: This was NOT an adverse event.  It was a vaccine administration error.  We thought we were administering the Pfizer bivalent vaccine and discovered in the mid afternoon on 9/8/22 that we were actually administering the Pfizer Grey Cap (monovalent/original) formulation of the vaccine.  Upon discovery corrective action was taken.  Patient was notified of vaccine administration error as was the Department of Health.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Autopsy, COVID-19, Death, Myocarditis, SARS-CoV-2 test positive
Clinical narrative: The decedent received the second dose of the COVID vaccine on 7/29/2022.  She began vomiting at bedtime on 8/1/2022 and was found unresponsive the morning of 8/2/2022.  She was transported to the emergency room by EMS where pronounced.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Unresponsive to stimuli, Vomiting
Clinical narrative: The decedent received the second dose of the COVID vaccine on 7/29/2022.  She began vomiting at bedtime on 8/1/2022 and was found unresponsive the morning of 8/2/2022.  She was transported to the emergency room by EMS where pronounced.
Age: 51.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Vaccine logistician drew up 0.5 mL of Pfizer Bivalent instead of 0.3 mL, the 0.5 mL
Age: 0.33
Sex: M
Vaccine: RV5
Symptoms: Expired product administered
Clinical narrative: expired dose given No symptoms  unexpired dose given same day
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Pruritus, Rash vesicular
Clinical narrative: Itchy, red palms and itchy, red soles of feet. Blister rash spreading down back of both legs from buttocks to knees.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered the vaccine which was past the manufacturers expiration date.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: This was NOT an adverse event.  It was a vaccine administration error.  We thought we were administering the Pfizer bivalent vaccine and discovered in the mid afternoon on 9/8/22 that we were actually administering the Pfizer Grey Cap (monovalent/original) formulation of the vaccine.  Upon discovery corrective action was taken.  Patient was notified of vaccine administration error as was the healthcare provider.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Tremor
Clinical narrative: Internal and external tremors, and extreme fatigue.
Age: 51.0
Sex: F
Vaccine: FLU4, FLU4, UNK
Symptoms: Hypersensitivity, Ocular hyperaemia, Swelling face
Clinical narrative: MINOR ALLERGIC REACTION... red eyes, patient c/o facial swelling Benadryl  PO 50mg/20ml administered. Pt. left alert and oriented
Age: 51.0
Sex: F
Vaccine: FLU4, FLU4, UNK
Symptoms: Lip swelling, Pruritus, Swelling face, Swelling of eyelid
Clinical narrative: MINOR ALLERGIC REACTION... red eyes, patient c/o facial swelling Benadryl  PO 50mg/20ml administered. Pt. left alert and oriented
Age: 51.0
Sex: F
Vaccine: FLU4, FLU4, UNK
Symptoms: Dysphonia, Dyspnoea, Swelling face, Swelling of eyelid
Clinical narrative: MINOR ALLERGIC REACTION... red eyes, patient c/o facial swelling Benadryl  PO 50mg/20ml administered. Pt. left alert and oriented
Age: 51.0
Sex: F
Vaccine: FLU4, FLU4, UNK
Symptoms: Hypersensitivity, Ocular hyperaemia, Swelling face
Clinical narrative: Facial swelling of face, eyelids, lips, itchy palms
Age: 51.0
Sex: F
Vaccine: FLU4, FLU4, UNK
Symptoms: Lip swelling, Pruritus, Swelling face, Swelling of eyelid
Clinical narrative: Facial swelling of face, eyelids, lips, itchy palms
Age: 51.0
Sex: F
Vaccine: FLU4, FLU4, UNK
Symptoms: Dysphonia, Dyspnoea, Swelling face, Swelling of eyelid
Clinical narrative: Facial swelling of face, eyelids, lips, itchy palms
Age: 70.0
Sex: M
Vaccine: FLU4
Symptoms: Painful respiration
Clinical narrative: Painful to inhale on right side of thorax.  Almost like having pleurisy
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: This was NOT an adverse event.  It was a vaccine administration error.  We thought we were administering the Pfizer bivalent vaccine and discovered in the mid afternoon on 9/8/22 that we were actually administering the Pfizer Grey Cap (monovalent/original) formulation of the vaccine.  Upon discovery corrective action was taken.  Patient was notified of vaccine administration error as was the regulatory authority.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 5.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered a vaccine past the manufacturer's expiration date.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, COVID-19, Chest X-ray normal, Cognitive disorder
Clinical narrative: Assessment and Plan Patient is a 78 y.o. male patient with history of prostate CA, depression, CAD, hypertension, hyperlipidemia, migraines, OSA presented with weakness and falls.    Frequent falls Generalized weakness  Ongoing issue for past 6 months to 1 year, subacute worsening with daily falls for the past 1 week Falls certainly multifactorial due to weakness, though history is non specific  Likely acutely worsened by COVID-19 infection and underlying gait/balance disturbance  CT Head (8/17) non acute, but does mention diffusely enlarged ventricles/sulci CT C-spine (8/17) negative for fracture or injury MRI with chronic microvascular changes Echo stable  Less likely seizure activity - some post fall shaking noted, no post ictal state  PT/OT following  Patient was evaluated and was initially recommended He has improved, reevaluated by PT and OT and home with home health recommended. Social worker contacted and arrangements have been made prior to discharge.   Covid-19 Virus Infection Date of onset of symptoms: 2-3 days prior to admission Symptoms present on admission: Cough, rhinorrhea, sore throat, headache, generalized weakness, falls Date of covid positive test: 8/17/2022 Vaccination status: vaccinated Imaging: Chest x-ray nonacute Oxygen requirements on admission: Room air Current O2 requirements: Room air Medical therapy: Started on Remdesivir and Dexamethasone  No longer hypoxic, steroid was stopped on 8/21 Will complete a 5-day course of remdesivir IV prior to discharge today Consultants following: NA Anticipated special isolation end date: 8/25/22   Mild cognitive impairment Some concern for dementia during a recent hospitalization, was seen by neurology and follow-up with improvement Clinical course consistent with MCI/early dementia Due for follow-up with neurology versus center  Hypokalemia Supplement orally.   Leukopenia Thrombocytopenia, POA Likely related to Covid infection  Has had some chronic thrombocytopenia in the past as well Plt 91k on admission, now improved to 130 K Will need opt follow up with PCP    Hx prostate CA Chronic urinary incontinence Following with urology, seen by doctor on 8/16 On active surveillance only, but PSA rising  Plans for outpatient MRI and biopsy Patient to follow-up with urology as outpatient.   Hypertension  BP elevated on admission, pt did not take home medications Resumed home amlodipine and hydrochlorothiazide Resume home regimen at discharge.   Hyperlipidemia Resumed home   OSA CPAP nightly
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram head abnormal, Computerised tomogram spine, Condition aggravated, Cough, Echocardiogram normal
Clinical narrative: Assessment and Plan Patient is a 78 y.o. male patient with history of prostate CA, depression, CAD, hypertension, hyperlipidemia, migraines, OSA presented with weakness and falls.    Frequent falls Generalized weakness  Ongoing issue for past 6 months to 1 year, subacute worsening with daily falls for the past 1 week Falls certainly multifactorial due to weakness, though history is non specific  Likely acutely worsened by COVID-19 infection and underlying gait/balance disturbance  CT Head (8/17) non acute, but does mention diffusely enlarged ventricles/sulci CT C-spine (8/17) negative for fracture or injury MRI with chronic microvascular changes Echo stable  Less likely seizure activity - some post fall shaking noted, no post ictal state  PT/OT following  Patient was evaluated and was initially recommended He has improved, reevaluated by PT and OT and home with home health recommended. Social worker contacted and arrangements have been made prior to discharge.   Covid-19 Virus Infection Date of onset of symptoms: 2-3 days prior to admission Symptoms present on admission: Cough, rhinorrhea, sore throat, headache, generalized weakness, falls Date of covid positive test: 8/17/2022 Vaccination status: vaccinated Imaging: Chest x-ray nonacute Oxygen requirements on admission: Room air Current O2 requirements: Room air Medical therapy: Started on Remdesivir and Dexamethasone  No longer hypoxic, steroid was stopped on 8/21 Will complete a 5-day course of remdesivir IV prior to discharge today Consultants following: NA Anticipated special isolation end date: 8/25/22   Mild cognitive impairment Some concern for dementia during a recent hospitalization, was seen by neurology and follow-up with improvement Clinical course consistent with MCI/early dementia Due for follow-up with neurology versus center  Hypokalemia Supplement orally.   Leukopenia Thrombocytopenia, POA Likely related to Covid infection  Has had some chronic thrombocytopenia in the past as well Plt 91k on admission, now improved to 130 K Will need opt follow up with PCP    Hx prostate CA Chronic urinary incontinence Following with urology, seen by doctor on 8/16 On active surveillance only, but PSA rising  Plans for outpatient MRI and biopsy Patient to follow-up with urology as outpatient.   Hypertension  BP elevated on admission, pt did not take home medications Resumed home amlodipine and hydrochlorothiazide Resume home regimen at discharge.   Hyperlipidemia Resumed home   OSA CPAP nightly
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Gait disturbance, Headache, Hyperlipidaemia, Hypertension
Clinical narrative: Assessment and Plan Patient is a 78 y.o. male patient with history of prostate CA, depression, CAD, hypertension, hyperlipidemia, migraines, OSA presented with weakness and falls.    Frequent falls Generalized weakness  Ongoing issue for past 6 months to 1 year, subacute worsening with daily falls for the past 1 week Falls certainly multifactorial due to weakness, though history is non specific  Likely acutely worsened by COVID-19 infection and underlying gait/balance disturbance  CT Head (8/17) non acute, but does mention diffusely enlarged ventricles/sulci CT C-spine (8/17) negative for fracture or injury MRI with chronic microvascular changes Echo stable  Less likely seizure activity - some post fall shaking noted, no post ictal state  PT/OT following  Patient was evaluated and was initially recommended He has improved, reevaluated by PT and OT and home with home health recommended. Social worker contacted and arrangements have been made prior to discharge.   Covid-19 Virus Infection Date of onset of symptoms: 2-3 days prior to admission Symptoms present on admission: Cough, rhinorrhea, sore throat, headache, generalized weakness, falls Date of covid positive test: 8/17/2022 Vaccination status: vaccinated Imaging: Chest x-ray nonacute Oxygen requirements on admission: Room air Current O2 requirements: Room air Medical therapy: Started on Remdesivir and Dexamethasone  No longer hypoxic, steroid was stopped on 8/21 Will complete a 5-day course of remdesivir IV prior to discharge today Consultants following: NA Anticipated special isolation end date: 8/25/22   Mild cognitive impairment Some concern for dementia during a recent hospitalization, was seen by neurology and follow-up with improvement Clinical course consistent with MCI/early dementia Due for follow-up with neurology versus center  Hypokalemia Supplement orally.   Leukopenia Thrombocytopenia, POA Likely related to Covid infection  Has had some chronic thrombocytopenia in the past as well Plt 91k on admission, now improved to 130 K Will need opt follow up with PCP    Hx prostate CA Chronic urinary incontinence Following with urology, seen by doctor on 8/16 On active surveillance only, but PSA rising  Plans for outpatient MRI and biopsy Patient to follow-up with urology as outpatient.   Hypertension  BP elevated on admission, pt did not take home medications Resumed home amlodipine and hydrochlorothiazide Resume home regimen at discharge.   Hyperlipidemia Resumed home   OSA CPAP nightly
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Hypokalaemia, Leukopenia, Magnetic resonance imaging abnormal, Obstructive sleep apnoea syndrome, Oropharyngeal pain
Clinical narrative: Assessment and Plan Patient is a 78 y.o. male patient with history of prostate CA, depression, CAD, hypertension, hyperlipidemia, migraines, OSA presented with weakness and falls.    Frequent falls Generalized weakness  Ongoing issue for past 6 months to 1 year, subacute worsening with daily falls for the past 1 week Falls certainly multifactorial due to weakness, though history is non specific  Likely acutely worsened by COVID-19 infection and underlying gait/balance disturbance  CT Head (8/17) non acute, but does mention diffusely enlarged ventricles/sulci CT C-spine (8/17) negative for fracture or injury MRI with chronic microvascular changes Echo stable  Less likely seizure activity - some post fall shaking noted, no post ictal state  PT/OT following  Patient was evaluated and was initially recommended He has improved, reevaluated by PT and OT and home with home health recommended. Social worker contacted and arrangements have been made prior to discharge.   Covid-19 Virus Infection Date of onset of symptoms: 2-3 days prior to admission Symptoms present on admission: Cough, rhinorrhea, sore throat, headache, generalized weakness, falls Date of covid positive test: 8/17/2022 Vaccination status: vaccinated Imaging: Chest x-ray nonacute Oxygen requirements on admission: Room air Current O2 requirements: Room air Medical therapy: Started on Remdesivir and Dexamethasone  No longer hypoxic, steroid was stopped on 8/21 Will complete a 5-day course of remdesivir IV prior to discharge today Consultants following: NA Anticipated special isolation end date: 8/25/22   Mild cognitive impairment Some concern for dementia during a recent hospitalization, was seen by neurology and follow-up with improvement Clinical course consistent with MCI/early dementia Due for follow-up with neurology versus center  Hypokalemia Supplement orally.   Leukopenia Thrombocytopenia, POA Likely related to Covid infection  Has had some chronic thrombocytopenia in the past as well Plt 91k on admission, now improved to 130 K Will need opt follow up with PCP    Hx prostate CA Chronic urinary incontinence Following with urology, seen by doctor on 8/16 On active surveillance only, but PSA rising  Plans for outpatient MRI and biopsy Patient to follow-up with urology as outpatient.   Hypertension  BP elevated on admission, pt did not take home medications Resumed home amlodipine and hydrochlorothiazide Resume home regimen at discharge.   Hyperlipidemia Resumed home   OSA CPAP nightly
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Platelet count decreased, Positive airway pressure therapy, Prostatic specific antigen increased, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Assessment and Plan Patient is a 78 y.o. male patient with history of prostate CA, depression, CAD, hypertension, hyperlipidemia, migraines, OSA presented with weakness and falls.    Frequent falls Generalized weakness  Ongoing issue for past 6 months to 1 year, subacute worsening with daily falls for the past 1 week Falls certainly multifactorial due to weakness, though history is non specific  Likely acutely worsened by COVID-19 infection and underlying gait/balance disturbance  CT Head (8/17) non acute, but does mention diffusely enlarged ventricles/sulci CT C-spine (8/17) negative for fracture or injury MRI with chronic microvascular changes Echo stable  Less likely seizure activity - some post fall shaking noted, no post ictal state  PT/OT following  Patient was evaluated and was initially recommended He has improved, reevaluated by PT and OT and home with home health recommended. Social worker contacted and arrangements have been made prior to discharge.   Covid-19 Virus Infection Date of onset of symptoms: 2-3 days prior to admission Symptoms present on admission: Cough, rhinorrhea, sore throat, headache, generalized weakness, falls Date of covid positive test: 8/17/2022 Vaccination status: vaccinated Imaging: Chest x-ray nonacute Oxygen requirements on admission: Room air Current O2 requirements: Room air Medical therapy: Started on Remdesivir and Dexamethasone  No longer hypoxic, steroid was stopped on 8/21 Will complete a 5-day course of remdesivir IV prior to discharge today Consultants following: NA Anticipated special isolation end date: 8/25/22   Mild cognitive impairment Some concern for dementia during a recent hospitalization, was seen by neurology and follow-up with improvement Clinical course consistent with MCI/early dementia Due for follow-up with neurology versus center  Hypokalemia Supplement orally.   Leukopenia Thrombocytopenia, POA Likely related to Covid infection  Has had some chronic thrombocytopenia in the past as well Plt 91k on admission, now improved to 130 K Will need opt follow up with PCP    Hx prostate CA Chronic urinary incontinence Following with urology, seen by doctor on 8/16 On active surveillance only, but PSA rising  Plans for outpatient MRI and biopsy Patient to follow-up with urology as outpatient.   Hypertension  BP elevated on admission, pt did not take home medications Resumed home amlodipine and hydrochlorothiazide Resume home regimen at discharge.   Hyperlipidemia Resumed home   OSA CPAP nightly
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Thrombocytopenia, Tremor, Ventricular enlargement
Clinical narrative: Assessment and Plan Patient is a 78 y.o. male patient with history of prostate CA, depression, CAD, hypertension, hyperlipidemia, migraines, OSA presented with weakness and falls.    Frequent falls Generalized weakness  Ongoing issue for past 6 months to 1 year, subacute worsening with daily falls for the past 1 week Falls certainly multifactorial due to weakness, though history is non specific  Likely acutely worsened by COVID-19 infection and underlying gait/balance disturbance  CT Head (8/17) non acute, but does mention diffusely enlarged ventricles/sulci CT C-spine (8/17) negative for fracture or injury MRI with chronic microvascular changes Echo stable  Less likely seizure activity - some post fall shaking noted, no post ictal state  PT/OT following  Patient was evaluated and was initially recommended He has improved, reevaluated by PT and OT and home with home health recommended. Social worker contacted and arrangements have been made prior to discharge.   Covid-19 Virus Infection Date of onset of symptoms: 2-3 days prior to admission Symptoms present on admission: Cough, rhinorrhea, sore throat, headache, generalized weakness, falls Date of covid positive test: 8/17/2022 Vaccination status: vaccinated Imaging: Chest x-ray nonacute Oxygen requirements on admission: Room air Current O2 requirements: Room air Medical therapy: Started on Remdesivir and Dexamethasone  No longer hypoxic, steroid was stopped on 8/21 Will complete a 5-day course of remdesivir IV prior to discharge today Consultants following: NA Anticipated special isolation end date: 8/25/22   Mild cognitive impairment Some concern for dementia during a recent hospitalization, was seen by neurology and follow-up with improvement Clinical course consistent with MCI/early dementia Due for follow-up with neurology versus center  Hypokalemia Supplement orally.   Leukopenia Thrombocytopenia, POA Likely related to Covid infection  Has had some chronic thrombocytopenia in the past as well Plt 91k on admission, now improved to 130 K Will need opt follow up with PCP    Hx prostate CA Chronic urinary incontinence Following with urology, seen by doctor on 8/16 On active surveillance only, but PSA rising  Plans for outpatient MRI and biopsy Patient to follow-up with urology as outpatient.   Hypertension  BP elevated on admission, pt did not take home medications Resumed home amlodipine and hydrochlorothiazide Resume home regimen at discharge.   Hyperlipidemia Resumed home   OSA CPAP nightly
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: This was NOT an adverse event.  It was a vaccine administration error.  We thought we were administering the Pfizer bivalent vaccine and discovered in the mid afternoon on 9/8/22 that we were actually administering the Pfizer Grey Cap (monovalent/original) formulation of the vaccine.  Upon discovery corrective action was taken.  Patient was notified of vaccine administration error as was the Department of Health.
Age: 12.0
Sex: F
Vaccine: HPV9, MMR, MNQ, TDAP
Symptoms: Incorrect route of product administration, No adverse event
Clinical narrative: patient was given an IM inject when the vaccination was to be given as subcutaneous injection, patient has not had any adverse symptoms as of this time.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: This was NOT an adverse event.  It was a vaccine administration error.  We thought we were administering the Pfizer bivalent vaccine and discovered in the mid afternoon on 9/8/22 that we were actually administering the Pfizer Grey Cap (monovalent/original) formulation of the vaccine.  Upon discovery corrective action was taken.  Patient was notified of vaccine administration error as was the regulatory authority.
Age: 72.0
Sex: F
Vaccine: FLU4
Symptoms: Pain in extremity, Paraesthesia, Vaccination site erythema
Clinical narrative: Redness several inches under the vaccine administration sight, deep, throbbing, tingling  ache/pain down the arm and into the fingers that (patient said it feels similar to a sprain),
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: This was NOT an adverse event.  It was a vaccine administration error.  We thought we were administering the Pfizer bivalent vaccine and discovered in the mid afternoon on 9/8/22 that we were actually administering the Pfizer Grey Cap (monovalent/original) formulation of the vaccine.  Upon discovery corrective action was taken.  Patient was notified of vaccine administration error as was the local Department of Health.
Age: 66.0
Sex: F
Vaccine: COVID19-2, FLU4, FLU4
Symptoms: Injection site pain, Pain
Clinical narrative: The patient is complaining of right shoulder pain after receiving the vaccine.  She said after the initial vaccine soreness went away she continued to have shoulder pain when moving her arm across her body or reaching behind her head.
Age: 66.0
Sex: F
Vaccine: COVID19-2, FLU4, FLU4
Symptoms: Immediate post-injection reaction, Injection site pain, Product administered at inappropriate site
Clinical narrative: The patient is complaining of right shoulder pain after receiving the vaccine.  She said after the initial vaccine soreness went away she continued to have shoulder pain when moving her arm across her body or reaching behind her head.
Age: 11.0
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Provided Trumemba (Meningococcal B) to a 11 year-9 month old instead of Menongiococcal Conjugate.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: This was NOT an adverse event. It was a vaccine administration error. We thought we were administering the Pfizer bivalent vaccine and discovered in the mid afternoon on 9/8/22 that we were actually administering the Pfizer Grey Cap (monovalent/original) formulation of the vaccine. Upon discovery corrective action was taken. Patient was notified of vaccine administration error as was the local health department.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: This was NOT an adverse event.  It was a vaccine administration error.  We thought we were administering the Pfizer bivalent vaccine and discovered in the mid afternoon on 9/8/22 that we were actually administering the Pfizer Grey Cap (monovalent/original) formulation of the vaccine.  Upon discovery corrective action was taken.  Patient was notified of vaccine administration error as was the Department of Health.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Gave the wrong age group vaccine to patient
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Expired product administered, No adverse event
Clinical narrative: medical assistant gave expired vaccine, no reaction from patient at this time
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: I began noticing hair loss that was greater than I normally experience. It has continued from the time COVID-19 began to the present time. At the present time, I have about one third the amount of hair. I?m not sure if it is vaccine related, but I wanted to report it in case anyone else is experiencing the same issue.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event, Product administration error
Clinical narrative: This was NOT an adverse event.  It was a vaccine administration error.  We thought we were administering the Pfizer bivalent vaccine and discovered in the mid afternoon on 9/8/22 that we were actually administering the Pfizer Grey Cap (monovalent/original) formulation of the vaccine.  Upon discovery corrective action was taken.  Patient was notified of vaccine administration error as was the Department of Health.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood cholesterol increased, Blood test, Urticaria
Clinical narrative: I got hives all over me and took Benadryl a couple of times and they didn't go away. I went to a doctor and was told I had Shingles and was given an antiviral. Then I felt worse  and had an anaphylactic shock  reaction, my tongue and lips got numb to the antiviral and was taken to the hospital for observation. When I returned home and saw my main doctor and was informed I didn't have Shingles. The hives are slowly going away.